Moxifloxacin Hydrochloride (Tablet)
Generic / Active Ingredient
What is Moxifloxacin Hydrochloride (Tablet) used for?
Acute bacterial sinusitis
22 Moxifloxacin Hydrochloride (Tablet) brands in Bangladesh
Compare prices across every brand of Moxifloxacin Hydrochloride (Tablet) and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| Floromox | 400 mg | Tablet | Ibn Sina Pharmaceuticals Ltd. | ৳ 30.00 |
| Floxalone | 400 mg | Tablet | Drug International Ltd. | ৳ 35.00 |
| Iventi | 400 mg | Tablet | Square Pharmaceuticals Ltd. | ৳ 40.00 |
| MQ-4 | 400 mg | Tablet | Silco Pharmaceutical Ltd. | ৳ 40.00 |
| Maxiflox | 400 mg | Tablet | ACI Limited | ৳ 35.00 |
| Maximox | 400 mg | Tablet | Orion Pharma Ltd. | ৳ 40.00 |
| Moxibac | 400 mg | Tablet | Popular Pharmaceuticals Ltd. | ৳ 70.00 |
| Moxier | 400 mg | Tablet | Euro Pharma Ltd. | ৳ 40.00 |
| Moxif | 400 mg | Tablet | Biopharma Laboratories Ltd. | ৳ 40.00 |
| Moxifix | 400 mg | Tablet | ACME Laboratories Ltd. | ৳ 40.00 |
| Moxiflox | 400 mg | Tablet | Alco Pharma Ltd. | ৳ 50.15 |
| Moxigen | 400 mg | Tablet | General Pharmaceuticals Ltd. | ৳ 40.00 |
| Moxilocin | 400 mg | Tablet | Opsonin Pharma Ltd. | ৳ 40.00 |
| Moxquin | 400 mg | Tablet | Incepta Pharmaceuticals Ltd. | ৳ 40.00 |
| Odycin | 400 mg | Tablet | Beximco Pharmaceuticals Ltd. | ৳ 40.00 |
| Optimox | 400 mg | Tablet | Aristopharma Ltd. | ৳ 40.00 |
| Respamox | 400 mg | Tablet | Somatec Pharmaceuticals Ltd. | ৳ 40.00 |
| Revalon | 400 mg | Tablet | NIPRO JMI Pharma Ltd. | ৳ 30.00 |
| Topomox | 400 mg | Tablet | Leon Pharmaceuticals Ltd. | ৳ 40.00 |
| Visomox | 400 mg | Tablet | Eskayef Pharmaceuticals Ltd. | ৳ 40.00 |
| Xiomox | 400 mg | Tablet | Renata Limited | ৳ 40.00 |
| Zydus | 400 mg | Tablet | Healthcare Pharmaceuticals Ltd. | ৳ 40.00 |
Indication DetailsView
Moxifloxacin is indicated for the treatment of acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community acquired pneumonia, uncomplicated & complicated skin and skin structure infections, complicated intra-abdominal infections and pelvic inflammatory disease.
Therapeutic ClassView
4-Quinolone preparations
PharmacologyView
Moxifloxacin is a 4th generation synthetic broad spectrum, fluoroquinolone class of antibacterial drug. It has activity against a wide range of gram-positive, gram-negative, anaerobic and atypical bacteria including Mycoplasma pneumoniae. It acts by inhibiting topoisomerase II (DNA gyrase) and topoisomerase IV which are necessary for bacterial DNA replication, transcription & repair.
DosageView
Acute bacterial sinusitis: 400 mg once daily 7-10 days.
Acute bacterial exacerbation of chronic bronchitis: 400 mg once daily 5-10 days.
Community-acquired pneumonia: 400 mg once daily 7-14 days.
Uncomplicated skin and skin structure infections: 400 mg once daily 7 days.
Complicated skin and skin structure infections: 400 mg once daily 7-21 days.
Complicated intra-abdominal infections: 400 mg once daily 5-14 days.
Pelvic inflammatory disease: 400 mg once daily 14 days.
Acute bacterial exacerbation of chronic bronchitis: 400 mg once daily 5-10 days.
Community-acquired pneumonia: 400 mg once daily 7-14 days.
Uncomplicated skin and skin structure infections: 400 mg once daily 7 days.
Complicated skin and skin structure infections: 400 mg once daily 7-21 days.
Complicated intra-abdominal infections: 400 mg once daily 5-14 days.
Pelvic inflammatory disease: 400 mg once daily 14 days.
Side EffectsView
Common side effects of Moxifloxacin include nausea, vomiting, diarrhea, headache and dizziness.
ContraindicationsView
It is contraindicated in patients with a history of hypersensitivity to Moxifloxacin or other quinolones.
PrecautionsView
Moxifloxacin may cause an increased risk of tendinitis and tendon rupture. It should be discontinued if pain or inflammation in a tendon occurs. It should not be used in patients with known prolongation of the QT interval, patients with uncorrected hypokalemia, and patients with receiving Class IA or Class III antiarrhythmic agents
InteractionsView
Moxifloxacin absorption is decreased when administered with antacids, sucralfate, multivitamins, and multivalent cations (e.g. iron or zinc). Moxifloxacin may enhance the risk of convulsions with NSAIDs and bleeding with warfarin. So concomitant use of Moxifloxacin with them should be avoided.
Pregnancy & LactationView
US FDA pregnancy category C. Moxifloxacin is not recommended during pregnancy & lactation.
Pediatric UsageView
Renal or hepatic impaired patients: No dose adjustment is necessary for patients with renal or hepatic impairment.
Pediatric patients: Safety and effectiveness of Moxifloxacin in pediatric patients and adolescent less than 18 years of age have not been established.
Pediatric patients: Safety and effectiveness of Moxifloxacin in pediatric patients and adolescent less than 18 years of age have not been established.
Storage ConditionsView
Keep in a dry place, away from light and heat. Keep out of the reach of children.